- Monogenic diabetes: recent updates on diagnosis and precision treatment: A narrative review
-
Jang KM
- KMID: 2538085
- Precis Future Med.
- 2022 Dec;6(4):209-217.
- doi: 10.23838/pfm.2022.00121
Monogenic diabetes is commonly caused by single-gene mutations. This disease ranges from 1% to 5% in all cases of diabetes and is less affected by behavior and environment. Neonatal diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- The genetics of obesity: A narrative review
-
Sohn YB
- KMID: 2538087
- Precis Future Med.
- 2022 Dec;6(4):226-232.
- doi: 10.23838/pfm.2022.00156
Monogenic obesity is a rare, early-onset, and severe form of obesity that has a Mendelian inheritance pattern, high penetrance, and large genetic effect. In contrast, common polygenic obesity is more... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical effectiveness and prospects of methylene blue: A systematic review
-
Seitkazina A, Yang JK, Kim S
- KMID: 2538084
- Precis Future Med.
- 2022 Dec;6(4):193-208.
- doi: 10.23838/pfm.2022.00079
Methylene blue (MB) is a well-known pharmaceutical ingredient that is thought to have a multi-targeted therapeutic effect as an anti-malarial and neuroprotective agent and has recently been identified as a... -
- CITED
-
- Close
- SHARE
-
- Close
- A new era of genetic diagnosis for short stature children: A review
-
Kim YM
- KMID: 2538086
- Precis Future Med.
- 2022 Dec;6(4):218-225.
- doi: 10.23838/pfm.2022.00142
Children with short stature are often presented to pediatric endocrinologists. Short stature is defined as the height that is more than two standard deviations below the corresponding mean height for... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of MET alteration in EGFR-mutant non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor from paired biopsy: A retrospective cohort study
-
Ku BM, Park S, Park S, Jung HA, Sun JM, Lee SH, Ahn JS, Choi YL, Ahn MJ
- KMID: 2538088
- Precis Future Med.
- 2022 Dec;6(4):233-242.
- doi: 10.23838/pfm.2022.00058
Purpose: Mesenchymal-epithelial transition tyrosine kinase receptor (MET) amplification is one of the common acquired resistance mechanisms to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). To evaluate the usefulness... -
- CITED
-
- Close
- SHARE
-
- Close
